Peter C. Ungaro

Randomized Phase III Trial of Weekly Compared With Every-3-Weeks Paclitaxel for Metastatic Breast Cancer, With Trastuzumab for all HER-2 Overexpressors and Random Assignment to Trastuzumab or Not in HER-2 Nonoverexpressors: Final Results of Cancer and Leukemia Group B Protocol 9840

Andrew D. Seidman, Donald A. Berry, Constance Cirrincione et al. · Journal of Clinical Oncology · 2008 · 600 citations · Full text

Randomized Phase II Trial of Induction Chemotherapy Followed by Concurrent Chemotherapy and Dose-Escalated Thoracic Conformal Radiotherapy (74 Gy) in Stage III Non–Small-Cell Lung Cancer: CALGB 30105

Mark A. Socinski, A. William Blackstock, Jeffrey A. Bogart et al. · Journal of Clinical Oncology · 2008 · 177 citations

Cancer in thyroid nodules. A community hospital survey.

Emile E. Werk, Barbara M. Vernon, Jorge J. Gonzalez et al. · PubMed · 1984 · 103 citations

Thyroid Nodules, Percentage Cancer Index, Medicine +13

Toxic cure: Hyperfractionated radiotherapy with concurrent cisplatin and fluorouracil for Stage III and IVA head-and-neck cancer in the community

Patrick D. Maguire, Martin B. Meyerson, Charles R. Neal et al. · International Journal of Radiation Oncology*Biology*Physics · 2004 · 38 citations

Concurrent Cisplatin, Radiation Therapy, Medicine +8

Phase II Trial of Hyperfractionated Intensity-Modulated Radiation Therapy and Concurrent Weekly Cisplatin for Stage III and IVa Head-and-Neck Cancer

Patrick D. Maguire, Michael A. Papagikos, Sue Hamann et al. · International Journal of Radiation Oncology*Biology*Physics · 2010 · 37 citations · Full text

Radiation Medicine, Phase Ii Trial, Radiation Therapy +9